Loading organizations...

§ Private Equity · Kuala Lumpur, Malaysia
Private equity firm investing in bio-pharmaceuticals and new energy vehicles in China, established in 2013.
Heda Capital is a private equity firm based in Beijing, China, specializing in capital deployment across growth-stage and early-stage companies. The firm's investment strategy predominantly targets the dynamic bio-pharmaceuticals and new energy vehicles industries within the Chinese market, seeking to capitalize on sector-specific growth opportunities. Operating through a comprehensive business model of private equity investment and fund management, Heda Capital focuses on long-term value creation. Specific scale metrics, including assets under management, total funding raised, or employee headcount, are not publicly disclosed by the firm. Similarly, details regarding Heda Capital's portfolio companies, lead investors, or other recognizable names are not available in public sources, beyond the presence of its legal representatives and partners in Beijing. Established in 2013, the firm's founding members are not publicly known.
Heda Capital has 2 tracked investments across 2 companies. The latest tracked deal is Series B in Juxing New Materials in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 9, 2026 | Juxing New Materials | Series B | — | Aima Technology, Sichuan Venture Capital Jiazi Wutong Fund |
| Apr 1, 2019 | Citcon | $8.0M Series B | — | Amino Capital, Draper Associates, KRM Interests LLC, Tsvc Capital, SUE XU, Cyber Wisdom, Catherine Zhou, Light Bridge, TSVC, ZhenFund |